Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.06 USD | +0.86% | -0.14% | -3.55% |
Evolution of the average Target Price on Verrica Pharmaceuticals Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Verrica Pharmaceuticals Inc.
HC Wainwright | |
Needham & Co. | |
RBC Capital Markets | |
Jefferies & Co. | |
Brookline Capital Markets | |
Northland Securities |
EPS Revisions
- Stock Market
- Equities
- VRCA Stock
- Consensus Verrica Pharmaceuticals Inc.